Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3057% above fair value
$105.80−0.01 (-0.01%)
Close on Nov 12, 2026Market cap $60.98BP/E 59.8Yield –
Edwards Lifesciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Edwards Lifesciences's enterprise value was $57.46B on Nov 11, 2026, against $47.08B a year earlier. Over the last 5 years it ranged from $36.95B to $79.65B, with a median of $46.59B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $57.46B | +24.2% |
| 2025 | Dec 31, 2025 | $46.25B | +16.0% |
| 2024 | Dec 31, 2024 | $39.87B | -11.5% |
| 2023 | Dec 29, 2023 | $45.04B | -0.1% |
| 2022 | Dec 30, 2022 | $45.07B | -43.4% |
| 2021 | Dec 31, 2021 | $79.65B | +41.9% |
| 2020 | Dec 31, 2020 | $56.12B | +17.2% |
| 2019 | Dec 31, 2019 | $47.88B | +51.4% |
| 2018 | Dec 31, 2018 | $31.63B | +34.7% |
| 2017 | Dec 29, 2017 | $23.48B | +20.9% |
| 2016 | Dec 30, 2016 | $19.42B | +18.7% |
| 2015 | Dec 31, 2015 | $16.37B | +28.9% |
| 2014 | Dec 31, 2014 | $12.70B | +88.9% |
| 2013 | Dec 31, 2013 | $6.72B | -33.8% |
| 2012 | Dec 31, 2012 | $10.15B | +29.7% |
| 2011 | Dec 30, 2011 | $7.83B | -11.7% |
| 2010 | Dec 31, 2010 | $8.86B | +78.8% |
| 2009 | Dec 31, 2009 | $4.96B | – |
See a number that looks wrong?